Posting of Annual Report and Notice of AGM
The Company’s 2018 Annual Report has been posted to shareholders together with the Notice of Annual General Meeting and the associated form of proxy. The Company’s AGM will be held at the offices of Peel Hunt LLP, 120 London Wall, London, EC2Y 5ET, UK, on 6 November 2018 at 1pm.
Among the resolutions will be the declaration of a final dividend for the year ended 30 June 2018 of 14.0 pence per share giving a total dividend for the year of 24.0 pence per share. The final dividend will be paid on 6 December 2018 to shareholders on the register as at 9 November 2018, with a corresponding ex-Dividend date of 8 November 2018.
The final dividend of 14.0 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company’s Dividend Currency Election, or who register to do so by the close of business on 9 November 2018. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 9 November 2018.
The Annual Report, the Notice of AGM and related documents are available on the Company’s website at www.craneware.com
For further information, please contact:
|Craneware plc||Peel Hunt (NOMAD & Joint Broker)||Investec Bank (Joint Broker)||Alma (Financial PR)|
|+44 (0)131 550 3100||+44 (0)20 7418 8900||+44 (0)20 7597 5970||+44 (0)208 004 4217|
|Keith Neilson, CEO||Dan Webster||Patrick Robb||Caroline Forde|
|Craig Preston, CFO||George Sellar||Sebastian Lawrence||Robyn Fisher|
|Guy Pengelley||Henry Reast||Josh Royston|
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
You might also like...
Dec 21, 2018 | Announcements
Strong performance expected to deliver revenue and adjusted EBITDA growth in the range of 15% to 20% 21 December 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, notes the recent...read more
Nov 9, 2018 | Announcements
09 November 2018 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018. For those shareholders...read more